Manipulating Each MreB of Bdellovibrio bacteriovorus Gives Diverse Morphological and Predatory Phenotypes

We studied the two mreB genes, encoding actinlike cytoskeletal elements, in the predatory bacterium Bdellovibrio bacteriovorus. This bacterium enters and replicates within other Gram-negative bacteria by attack-phase Bdellovibrio squeezing through prey outer membrane, residing and growing filamentously in the prey periplasm forming an infective “bdelloplast,” and septating after 4 h, once the prey contents are consumed. This lifestyle brings challenges to the Bdellovibrio cytoskeleton. Both mreB genes were essential for viable predatory growth, but C-terminal green fluorescent protein tagging each separately with monomeric teal-fluorescent protein (mTFP) gave two strains with phenotypic changes at different stages in predatory growth and development. MreB1-mTFP cells arrested growth early in bdelloplast formation, despite successful degradation of prey nucleoid. A large population of stalled bdelloplasts formed in predatory cultures and predation proceeded very slowly. A small proportion of bdelloplasts lysed after several days, liberating MreB1-mTFP attack-phase cells of wild-type morphology; this process was aided by subinhibitory concentrations of an MreB-specific inhibitor, A22. MreB2-mTFP, in contrast, was predatory at an almost wild-type rate but yielded attack-phase cells with diverse morphologies, including spherical, elongated, and branched, the first time such phenotypes have been described. Wild-type predatory rates were seen for all but spherical morphotypes, and septation of elongated morphotypes was achieved by the addition of A22.The predatory bacterium Bdellovibrio bacteriovorus shows novel filamentous growth within the periplasm of the Gram-negative prey bacterium on which it feeds. This study focuses on the cytoskeletal protein MreB and the role that two homologues of it play in B. bacteriovorus predatory or host-dependent (HD) growth. The HD B. bacteriovorus life cycle can be split into two phases: an attack phase and a growth phase (Fig. ​(Fig.1).1). The attack-phase B. bacteriovorus is a small free-swimming, highly motile cell within which replication has been arrested and which does not take up organic nutrients from the environment or grow extensively (24, 26). Once an attack-phase cell has collided with a suitable prey bacterium, B. bacteriovorus opens and squeezes through a small hole, formed in the outer membrane, using type IV pili to pull itself inside (7, 10). The B. bacteriovorus reseals the hole upon entering the periplasm. Once inside, the prey is killed rapidly within 15 min, and the prey cell wall is partially digested (35), forming a rounded structure called the bdelloplast (see Fig. ​Fig.11 and 4Ac and d). The HD B. bacteriovorus cell then enters the second, growth phase, part of the life cycle, (Fig. ​(Fig.1),1), whereby it grows filamentously while simultaneously coordinating the digestion and transportation of monomers from the prey cytoplasm. The mature growth-phase cell is multiploid and elongates typically 3 to 10 times the length of an attack-phase cell, its length being a reflection of the nutritional resources available in the prey (20). Once resources within the bdelloplast are depleted, the mature filament septates sequentially from one pole to form multiple progeny. These lyse the exhausted bdelloplast, mature into attack-phase cells, and repress growth once again (Fig. ​(Fig.1).1). B. bacteriovorus can be cultured slowly, without prey, as host-independent (HI) cells growing upon peptone-rich medium (30). In these conditions they grow pleiomorphically as mainly long filamentous or serpentine cells, from which some small attack-phase cells septate (30).Open in a separate windowFIG. 1.Schematic host-dependent (HD) predatory cycle for B. bacteriovorus on E. coli prey, showing the different phases of growth and inferred demands on the B. bacteriovorus cell cytoskeleton. References where the roles of the cytoskeleton in cell development have been proven for other bacteria are provided in parentheses. The status of the prey genome is both drawn from an earlier study (26) and confirmed by our work in the present study (see Fig. ​Fig.44).The predatory lifestyle of B. bacteriovorus presents a number of novel developmental challenges to the B. bacteriovorus cell and its cytoskeleton. It is not known how the attack-phase cells deform, allowing the B. bacteriovorus to squeeze through a pore it makes in the prey outer membrane that is narrower than the width of an attack-phase cell, as was imaged by Burnham et al. in the 1960s and more recently by Evans et al. (7, 10). It is also not known how the growth-phase filamentous cell within the bdelloplast is generated and remains resistant to division until terminal sequential septation begins, despite having multiple potential sites for septation along its length while elongating.The processes of cell elongation in rod-shaped bacteria are coordinated by an internal MreB cell cytoskeleton (9). MreB is a eukaryotic actin homologue and has been well studied in Escherichia coli, Bacillus subtilis, and Caulobacter crescentus (38). MreB monomers polymerize on ATP binding, forming helical structures in vivo that appear to associate with the cytoplasmic side of the bacterial cytoplasmic membrane (11, 18, 31). Bacterial two-hybrid experiments in Escherichia coli suggest that MreB forms a transmembrane complex with the two proteins MreC and MreD, each of which have been shown to form helical structures in vivo (21). A complex of MreBCD, together with the RodA protein, influences the shape of the peptidoglycan cell wall and thus the shape of the cell by positioning the peptidoglycan biosynthetic machinery so that its action is directionally specific (9, 19, 37). The MreB filament has also been shown to have roles in chromosome segregation, septation, and cell polarity (13, 14, 22, 37).Depletion of the MreB protein levels in E. coli and B. subtilis led to cells taking on a spherical morphology and eventual loss of viability since new peptidoglycan is not synthesized evenly along the cell wall (9, 36). Uneven incorporation of new peptidoglycan is potentially driven by the tubulin homologue FtsZ (4, 36). A similar phenotype is achieved by addition of the MreB inhibitor A22 that causes the reversible loss of MreB filament localization in vivo (14, 17). A22 was discovered in a chemical library being screened for the ability to generate anucleate minicells from E. coli (16, 17). It has been used extensively by others to examine MreB function in bacteria of many different genera. The addition of A22 to E. coli cells at 3.13 μg/ml leads to the breakdown of MreB filaments, spheroplasting and the generation of minicells (16). In B. subtilis, A22 at concentrations in excess of 100 μg/ml is required to generate spheroplasts; in C. crescentus 6-h incubations of A22 at 10 μg/ml are needed before any change to the cell shape can be observed—in this case cells take on a characteristic “lemon shape” (14, 16). Isolation and sequencing of A22-resistant mutants of C. crescentus, as well as biochemical evidence from purified MreB from Thermotoga maritima, revealed that A22 binds in the nucleotide binding pocket of MreB (3, 14). In vitro light scattering assays of MreB filamentation showed that A22 acted as a competitive inhibitor of ATP binding and was able in inhibit the formation of MreB filaments, presumably by sequestering and inactivating MreB monomers preventing their recycling (3). This study also demonstrated that in vitro A22 can have a role in stabilizing ADP-bound MreB (3).In the present study we investigated the functions of the two MreB homologues found in B. bacteriovorus, testing the role each has in predation and cell morphology by a combination of genetic approaches and A22 treatment. A reduction in function in both MreB proteins, achieved by C-terminal teal fluorescent protein (TFP) tagging, suggests that the MreB1 (Bd0211) protein was required in the growth-phase cell in bdelloplasts, whereas the MreB2 (Bd1737) protein is required later in the predatory process, for maintaining and allowing successful resolution of the growth-phase filament into short attack-phase vibroid cells.     

Wnt3a-mediated chemorepulsion controls movement patterns of cardiac progenitors and requires RhoA function

The heart is the first organ to function during vertebrate development and cardiac progenitors are among the first cell lineages to be established. In the chick, cardiac progenitors have been mapped in the epiblast of pre-streak embryos, and in the early gastrula they are located in the mid-primitive streak, from which they enter the mesoderm bilaterally. Signals controlling the specification of cardiac cells have been well documented; however, migration routes of cardiac progenitors have not been directly observed within the embryo and the factor(s) controlling their movement are not known. In addition, it is not clear how cell movement is coordinated with cell specification in the early embryo. Here we use live imaging to show that cardiac progenitors migrate in highly directed trajectories, which can be controlled by Wnt3a. Ectopic Wnt3a altered movement trajectories and caused cardia bifida. This was rescued by electroporation of dominant-negative DN-Wnt3a into prospective cardiac cells. Explant essays and mutant analysis showed that cellular guidance involved repulsion in response to Wnt3a and required RhoA function. It has been shown that Wnt3a inhibits cardiogenic cell specification through a beta-catenin-dependent pathway. On the basis of our results, we propose that Wnt3a concomitantly guides the movement of cardiac progenitors by a novel mechanism involving RhoA-dependent chemorepulsion.     

Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity

The therapeutic potential of adoptive therapy using tumour-infiltrating lymphocytes (TIL) has been demonstrated in a number of clinical trials. However, freshly isolated tumour-infiltrating lymphocytes (TIL) are often impaired in their proliferative and cytotoxic responses, which limits their use in immunotherapy. Several hypotheses with regard to the poor effector function of TIL have been postulated, including the production of immunosuppressive factors by tumour cells. In a previous paper we reported the efficient expansion of immunoreactive TIL from a variety of solid tumours by stimulation with a combination of monoclonal antibodies (mAbs) against CD3 and CD28. In the present study we analysed whether this protocol would be improved by the removal of tumour cells at the start of the culture. We tested a highly immunogenic tumour, melanoma, and a poorly immunogenic tumour, colon carcinoma. Removal of tumour cells highly improved anti-CD3/CD28 stimulated expansion of TIL from colon carcinoma, resulting in a significantly higher percentage of potentially tumour-specific CD8-positive T-cells and a reduced CD4/CD8 ratio compared to expansion in the presence of tumour cells. In contrast, expansion and CD4/CD8 ratio of melanoma-derived TIL was not significantly influenced by the removal of autologous tumour cells. CD3/CD28-stimulated melanoma TIL cultured in the absence of tumour cells showed specific lysis of autologous tumour cells comparable to melanoma TIL cultured in high-dose IL2. However, no cytotoxicity could be detected in colon TIL irrespective of the culture conditions used. On the other hand, 3/8 colon carcinoma TIL cultures and 9/12 melanoma-derived TIL cultures showed IFN secretion upon stimulation with autologous tumour cells. We conclude that stimulation of TIL with a combination of mAbs to CD3 and CD28 in the absence of tumour cells induces efficient expansion of potentially tumour-specific cells from a highly and a poorly immunogenic tumour. Removal of tumour cells does not have a negative influence on the generation of tumour-specific T cells, while cell yield improves. Therefore, for large-scale cultures this protocol can efficiently induce the outgrowth of tumour-specific TIL, at the same time providing a useful source of autologous tumour cells that can be stored and used to direct or test antitumour specificity.     

Low bone mineral density in men with chronic obstructive pulmonary disease

Background

Osteoporosis is common in patients with COPD but the likely multi-factorial causes contributing to this condition (e.g. sex, age, smoking, therapy) mask the potential contribution from elements related to COPD. In order to study osteoporosis and bone mineral density (BMD) related to COPD, we studied a well-defined group of patients and controls.

Methods

BMD, forced expiratory volume in one second (FEV₁), circulating bone biomarkers and biochemistry were determined in 30 clinically stable male ex-smokers with confirmed COPD and 15 age matched "ex-smoker" male controls. None of the patients were on inhaled corticosteroids or received more than one short course of steroids.

Results

Mean (SD) FEV₁% predicted of patients was 64(6)%, the majority having Global Initiative for Chronic Obstructive Lung Disease (GOLD) II airflow obstruction. There were 5/30 patients and 1/15 controls who were osteoporotic, while a further 17 patients and 5 controls were osteopenic. The BMD at the hip was lower in patients than controls, but not at the lumbar spine. Mean values of procollagen type 1 amino-terminal propeptide and osteocalcin, both markers of bone formation, and Type 1 collagen β C-telopeptide, a marker of bone resorption, were similar between patients and controls. However, all bone biomarkers were inversely related to hip BMD in patients (r = -0.51, r = -0.67, r = -0.57, p < 0.05) but did not relate to lumbar spine BMD. 25-OH Vitamin D was lower in patients.

Conclusions

Men with COPD had a greater prevalence of osteoporosis and osteopenia than age matched male controls, with a marked difference in BMD at the hip. Bone biomarkers suggest increased bone turnover.     

Manipulating resource allocation in plants

The distribution of nutrients and assimilates in different organs and tissues is in a constant state of flux throughout the growth and development of a plant. At key stages during the life cycle profound changes occur, and perhaps one of the most critical of these is during seed filling. By restricting the competition for reserves in Arabidopsis plants, the ability to manipulate seed size, seed weight, or seed content has been explored. Removal of secondary inflorescences and lateral branches resulted in a stimulation of elongation of the primary inflorescence and an increase in the distance between siliques. The pruning treatment also led to the development of longer and larger siliques that contained fewer, bigger seeds. This seems to be a consequence of a reduction in the number of ovules that develop and an increase in the fatty acid content of the seeds that mature. The data show that shoot architecture could have a substantial impact on the partitioning of reserves between vegetative and reproductive tissues and could be an important trait for selection in rapid phenotyping screens to optimize crop performance.     

NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-γ-stimulated immune complex arthritis

In previous studies we have found that FcγRI determines chondrocyte death and matrix metalloproteinase (MMP)-mediated cartilage destruction during IFN-γ-regulated immune complex arthritis (ICA). Binding of immune complexes (ICs) to FcγRI leads to the prominent production of oxygen radicals. In the present study we investigated the contribution of NADPH-oxidase-driven oxygen radicals to cartilage destruction by using p47phox^-/- mice lacking a functional NADPH oxidase complex. Induction of a passive ICA in the knee joints of p47phox^-/- mice resulted in a significant elevation of joint inflammation at day 3 when compared with wild-type (WT) controls as studied by histology. However, when IFN-γ was overexpressed by injection of adenoviral IFN-γ in the knee joint before ICA induction, a similar influx of inflammatory cells was found at days 3 and 7, comprising mainly macrophages in both mouse strains. Proteoglycan depletion from the cartilage layers of the knee joints in both groups was similar at days 3 and 7. Aggrecan breakdown in cartilage caused by MMPs was further studied by immunolocalisation of MMP-mediated neoepitopes (VDIPEN). VDIPEN expression in the cartilage layers of arthritic knee joints was markedly lower (between 30 and 60%) in IFN-γ-stimulated arthritic p47phox^-/- mice at day 7 than in WT controls, despite significant upregulation of mRNA levels of various MMPs such as MMP-3, MMP-9, MMP-12 and MMP-13 in synovia and MMP-13 in cartilage layers as measured with quantitative RT-PCR. The latter observation suggests that oxygen radicals are involved in the activation of latent MMPs. Chondrocyte death, determined as the percentage of empty lacunae in articular cartilage, ranged between 20 and 60% at day 3 and between 30 and 80% at day 7 in WT mice, and was completely blocked in p47phox^-/- mice at both time points. FcγRI mRNA expression was significantly lower, and FcγRII and FcγRIII were higher, in p47phox^-/- mice than in controls. NADPH-oxidase-driven oxygen radical production determines chondrocyte death and aggravates MMP-mediated cartilage destruction during IFN-γ-stimulated IC-mediated arthritis. Upregulation of FcγRI by oxygen radicals may contribute to cartilage destruction.     

Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency

Background

Determining the presence and extent of co-morbidities is fundamental in assessing patients with chronic respiratory disease, where increased cardiovascular risk, presence of osteoporosis and low muscle mass have been recognised in several disease states. We hypothesised that the systemic consequences are evident in a further group of subjects with COPD due to Alpha-1 Antitrypsin Deficiency (A1ATD), yet are currently under-recognised.

Methods

We studied 19 patients with PiZZ A1ATD COPD and 20 age, sex and smoking matched controls, all subjects free from known cardiovascular disease. They underwent spirometry, haemodynamic measurements including aortic pulse wave velocity (aPWV), an independent predictor or cardiovascular risk, dual energy X-ray absorptiometry to determine body composition and bone mineral density.

Results

The aPWV was greater in patients: 9.9(2.1) m/s than controls: 8.5(1.6) m/s, p = 0.03, despite similar mean arterial pressure (MAP). The strongest predictors of aPWV were age, FEV₁% predicted and MAP (all p < 0.01). Osteoporosis was present in 8/19 patients (2/20 controls) and was previously unsuspected in 7 patients. The fat free mass and bone mineral density were lower in patients than controls (p < 0.001).

Conclusions

Patients with A1ATD related COPD have increased aortic stiffness suggesting increased risk of cardiovascular disease and evidence of occult musculoskeletal changes, all likely to contribute hugely to overall morbidity and mortality.     

VNTR analysis reveals unexpected genetic diversity within <Emphasis Type="Italic">Mycoplasma agalactiae</Emphasis>, the main causative agent of contagious agalactia

Background  

Mycoplasma agalactiae is the main cause of contagious agalactia, a serious disease of sheep and goats, which has major clinical and economic impacts. Previous studies of M. agalactiae have shown it to be unusually homogeneous and there are currently no available epidemiological techniques which enable a high degree of strain differentiation.     

A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumours

Summary Human recombinant DNA interferon gamma (IFN-G), with a specific activity of 2×10⁶ IU/mg protein, was administered s.c. 3 days per week for 2 months to patients with solid tumors. The maximum tolerated dose (MTD) was 10×10⁶ IU/m² (5.0 mg/m²) per injection, and six patients were treated at the MTD. Two of these ceased treatment because of severe subjective toxity (headache, rigors and pyrexia) and three patients developed WHO grade 3 leucopenia. Subjective toxicity varied considerably between patients and some patients at low dose levels experienced severe constitutional symptoms whilst others treated at the MTD had few side effects. These differences were unrelated to pharmacokinetic parameters. Bioavailability of this IFN-G administered s.c. was very variable from one patient to another at the same dose level. We therefore counsel caution in using this IFN-G preparation s.c. in phase II studies.